Icon (ICLR) Operating Expenses (2009 - 2026)
Icon's (ICLR) quarterly Operating Expenses came in at $1.9 billion in Q2 2026, up 6.5% year-over-year from $1.8 billion in Q2 2025, and up 3.52% quarter-over-quarter from $1.9 billion in Q1 2026.
Analysis
Icon (ICLR) Operating Expenses (2009 - 2026) Analysis & Trends
Icon (ICLR) has reported Operating Expenses for 18 consecutive years, with $1.9 billion the latest figure, recorded in Q2 2026.
- On a quarterly basis, Operating Expenses rose 6.5% year-over-year to $1.9 billion in Q2 2026; TTM through Jun 2026 was $7.6 billion, a 8.12% increase from a year earlier, with the FY2025 full-year figure at $7.8 billion, up 9.11% from the prior year.
- Operating Expenses was $1.9 billion for Q2 2026 at Icon, up from $1.9 billion in the prior quarter.
- Over five years, Operating Expenses peaked at $2.0 billion in Q3 2025 and troughed at $1.7 billion in Q3 2022.
- A 5-year average of $1.8 billion and a median of $1.8 billion in 2023 frame the typical range for Operating Expenses.
- The widest YoY moves for Operating Expenses: up 133.29% in 2022, down 8.73% in 2022.
- Over 5 years, Operating Expenses stood at $1.8 billion in 2022, then grew by 2.19% to $1.8 billion in 2023, then dropped by 3.65% to $1.7 billion in 2024, then grew by 10.0% to $1.9 billion in 2025, then advanced by 1.1% to $1.9 billion in 2026.
- The last three Operating Expenses figures came in at $1.9 billion (Q2 2026), $1.9 billion (Q1 2026), and $1.9 billion (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | 637.00 Mn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | 560.51 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | 1.93 Bn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 228.90 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | 663.40 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | 78.70 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | 15.64 Mn |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | 6.01 Bn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | 2.78 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.93 Bn |
| Mar 31, 2026 | 1.86 Bn |
| Dec 31, 2025 | 1.90 Bn |
| Sep 30, 2025 | 1.96 Bn |
| Jun 30, 2025 | 1.81 Bn |
| Mar 31, 2025 | 1.79 Bn |
| Dec 31, 2024 | 1.73 Bn |
| Sep 30, 2024 | 1.74 Bn |
| Jun 30, 2024 | 1.89 Bn |
| Mar 31, 2024 | 1.80 Bn |
| Dec 31, 2023 | 1.80 Bn |
| Sep 30, 2023 | 1.79 Bn |
| Jun 30, 2023 | 1.81 Bn |
| Mar 31, 2023 | 1.76 Bn |
| Dec 31, 2022 | 1.76 Bn |
| Sep 30, 2022 | 1.70 Bn |
| Jun 30, 2022 | 1.76 Bn |
| Mar 31, 2022 | 1.73 Bn |
| Dec 31, 2021 | 1.74 Bn |
| Sep 30, 2021 | 1.86 Bn |